Published in Ann N Y Acad Sci on April 15, 1992
Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides. J Clin Invest (1982) 2.01
Antimicrobial effects of alpha-MSH peptides. J Leukoc Biol (2000) 1.74
Inhibition of neutrophil oxidative metabolism by nimesulide. Agents Actions (1987) 1.73
The Diamond Blackfan Anemia Registry: tool for investigating the epidemiology and biology of Diamond-Blackfan anemia. J Pediatr Hematol Oncol (2001) 1.64
Treatment of Diamond-Blackfan anemia with recombinant human interleukin-3. Blood (1993) 1.58
Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995). Leukemia (2000) 1.58
Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study. Clin Exp Allergy (1996) 1.54
Plasma concentrations and anti-L-cytokine effects of alpha-melanocyte stimulating hormone in septic patients. Crit Care Med (2000) 1.53
Effects of three anesthetic induction techniques on heart rate variability. J Clin Anesth (1992) 1.52
Histiocytosis-X. N Engl J Med (1981) 1.51
The PLAT Study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients. Atherosclerosis (1991) 1.40
Chemicals and drugs as triggers of food-associated disorder. Ann Allergy (1988) 1.39
Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals. AIDS (1996) 1.39
Some negative aspects of sickle cell anemia screening programs (negative aspects of sickle cell screening). Conn Med (1974) 1.38
Erythroid failure in Diamond-Blackfan anemia is characterized by apoptosis. Blood (1994) 1.36
Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc Natl Acad Sci U S A (1995) 1.35
Thrombocytopenia with absent radii. A review of 100 cases. Am J Pediatr Hematol Oncol (1988) 1.33
HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection. Lancet (1986) 1.31
Structure and functions of Pseudomonas aeruginosa lipopolysaccharide. Antibiot Chemother (1971) (1985) 1.22
Anti-phospholipid and anti-mitochondrial type M5 antibodies in systemic lupus erythematosus. Clin Exp Rheumatol (1986) 1.22
alpha-MSH and its receptors in regulation of tumor necrosis factor-alpha production by human monocyte/macrophages. Am J Physiol (1999) 1.21
Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant (2008) 1.20
Some negative aspects of state health departments' policies related to screening for sickle cell anemia. Am J Public Health (1974) 1.19
Studies on the relationship between the level of specific IgE antibodies and the clinical expression of allergy: I. Definition of levels distinguishing patients with symptomatic from patients with asymptomatic allergy to common aeroallergens. J Allergy Clin Immunol (1995) 1.19
The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides (1996) 1.17
Esmolol attenuates cardiovascular responses to extubation. Anesth Analg (1990) 1.15
Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol (1988) 1.15
Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Bone Marrow Transplant (2001) 1.13
Evidence for linkage of familial Diamond-Blackfan anemia to chromosome 8p23.3-p22 and for non-19q non-8p disease. Blood (2001) 1.12
Autologous bone-marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in-vitro treatment with J5 monoclonal antibody and complement. Lancet (1982) 1.10
Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J Leukoc Biol (1998) 1.08
Thermosensitivity of medulla oblongata in control of body temperature. Am J Physiol (1973) 1.07
Bilateral microtia and cleft palate in cousins with Diamond-Blackfan anemia. Am J Med Genet (2001) 1.06
Amplification of band q22 of chromosome 21, including AML1, in older children with acute lymphoblastic leukemia: an emerging molecular cytogenetic subgroup. Leukemia (2003) 1.05
Eugenol: antipyretic activity in rabbits. Neuropharmacology (1987) 1.05
Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB. Brain Res (2000) 1.05
Persistence of febrile response to pyrogens after PO/AH lesions in squirrel monkeys. Am J Physiol (1976) 1.04
alpha-Melanocyte stimulating hormone in the modulation of host reactions. Endocr Rev (1993) 1.04
alpha-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line. J Leukoc Biol (1996) 1.03
Evidence for genetic restriction in the suppression of erythropoiesis by a unique subset of T lymphocytes in man. J Clin Invest (1983) 1.02
Liver transplantation in hepatitis delta virus disease. Lancet (1987) 1.02
Effects of sodium salicylate, aminopyrine and chlorpromazine on behavioral temperature regulation. Pharmacol Biochem Behav (1975) 1.02
Mature bone marrow erythroid burst-forming units do not require T cells for induction of erythropoietin-dependent differentiation. J Exp Med (1980) 1.02
Antiinflammatory influences of alpha-MSH molecules: central neurogenic and peripheral actions. J Neurosci (1994) 1.02
The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation (1994) 1.01
Prospective comparative evaluation of quantitative-elastosonography (Q-elastography) and contrast-enhanced ultrasound for the evaluation of thyroid nodules: preliminary experience. Eur J Radiol (2013) 1.00
Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from patients with essential mixed cryoglobulinemia. Clin Immunol Immunopathol (1984) 1.00
Anti-mitochondrial type M5 and anti-cardiolipin antibodies in autoimmune disorders: studies on their association and cross-reactivity. Clin Exp Immunol (1987) 0.99
Effects of brainstem lesions on temperature regulation in hot and cold environments. Am J Physiol (1974) 0.99
IL-10 up-regulates human monocyte phagocytosis in the presence of IL-4 and IFN-gamma. J Leukoc Biol (1995) 0.98
Expression of MY7 antigen on myeloid precursor cells. Int J Cell Cloning (1983) 0.98
Inhibition of peripheral NF-kappaB activation by central action of alpha-melanocyte-stimulating hormone. J Neuroimmunol (1999) 0.98
alpha-MSH modulates experimental inflammatory bowel disease. Peptides (1997) 0.98
Cytokine antagonists in aged subjects and their relation with cellular immunity. J Gerontol A Biol Sci Med Sci (1997) 0.97
Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide alpha-MSH. FASEB J (1989) 0.96
Impaired antipneumococcal antibody production in patients without spleens. Br Med J (Clin Res Ed) (1985) 0.96
Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement. Cancer Res (1983) 0.96
Virus and cell requirements for Friend virus granulocytic leukemogenesis in long-term bone marrow cultures of NIH swiss [N:NIH(S)] mice. J Natl Cancer Inst (1980) 0.96
Antipyretic potency of centrally administered alpha-melanocyte stimulating hormone. Science (1983) 0.95
N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours. Br J Cancer (2001) 0.95
Inosiplex in recurrent herpes simplex infections. Lancet (1982) 0.95
The effect of fever on central alpha-MSH concentrations in the rabbit. Peptides (1981) 0.94
Echocardiography and cardiac assist devices. Minerva Cardioangiol (2007) 0.94
An intrinsic progenitor defect in Diamond-Blackfan anaemia. Br J Haematol (1989) 0.94
Central administration of peptides alters thermoregulation in the rabbit. Peptides (1980) 0.93
Synthesis of hemoglobin F in adult simian erythroid progenitor-derived colonies. J Clin Invest (1982) 0.93
Secondary and essential cryoglobulinemias. Frequency, nosological classification, and long-term follow-up. Acta Haematol (1983) 0.93
Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. Italian Zidovudine Evaluation Group. JAMA (1992) 0.93
Control of the simian fetal hemoglobin switch at the progenitor cell level. J Clin Invest (1981) 0.93
Systemically administered alpha-melanocyte-stimulating peptides inhibit NF-kappaB activation in experimental brain inflammation. Brain Res (1999) 0.93
The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group. Arterioscler Thromb (1992) 0.92
Interleukin-10 down-regulates oxidative metabolism and antibody-dependent cellular cytotoxicity of human neutrophils. Scand J Immunol (1997) 0.92
Defective erythroid progenitor differentiation system in congenital hypoplastic (Diamond-Blackfan) anemia. Blood (1986) 0.92
Increased expression of IgG Fc receptor type I on neutrophils and monocytes from HIV-infected subjects. Clin Exp Immunol (1992) 0.91
Functional characterization of specific IgE antibodies for tetanus toxoid. Ric Clin Lab (1983) 0.91
The insulin analog aspart: a safe alternative in insulin allergy. Diabetes Care (2001) 0.91
Fever-specific changes in central MSH and CRF concentrations. Am J Physiol (1985) 0.90
Modification of rabbit head holder to increase speed and accuracy of stereotaxic surgery. Brain Res Bull (1977) 0.90
Relationship between anti-phospholipid and anti-endothelial cell antibodies: further characterization of the reactivity on resting and cytokine-activated endothelial cells. Clin Exp Rheumatol (1992) 0.90
Ketamine suppresses endotoxin-induced NF-kappaB expression. Can J Anaesth (2000) 0.90
Complementary lowering of the behavioural and physiological thermoregulatory set-points by tetrodotoxin and saxitoxin in the cat. J Physiol (1974) 0.89
Inhibition of acute inflammation in the periphery by central action of salicylates. Proc Natl Acad Sci U S A (1991) 0.89
Central neurogenic antiinflammatory action of alpha-MSH: modulation of peripheral inflammation induced by cytokines and other mediators of inflammation. Neuroendocrinology (1994) 0.89
Fatal cyclophosphamide-induced congestive heart failure in a 10-year-old boy with Shwachman-Diamond syndrome and severe bone marrow failure treated with allogeneic bone marrow transplantation. Am J Pediatr Hematol Oncol (1990) 0.89
Inhibition of systemic inflammation by central action of the neuropeptide alpha-melanocyte- stimulating hormone. Neuroimmunomodulation (1999) 0.89
Grass pollen immunotherapy: a single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitis. J Allergy Clin Immunol (1984) 0.89
Absence of common ALL antigen on normal bipotent myeloid, erythroid, and granulocyte progenitors. Blood (1981) 0.89
Cell-cell interactions in the regulation of erythropoiesis. Br J Haematol (1983) 0.89
Changes in body temperature after administration of amino acids, peptides, dopamine, neuroleptics and related agents: II. Neurosci Biobehav Rev (1985) 0.88
Peripheral administration of alpha-MSH reduces fever in older and younger rabbits. Peptides (1983) 0.88
Drug-related heatstroke. Pharmacol Ther (1984) 0.88
Changes in body temperature produced by injecting prostaglandin E1, EGTA and bacterial endotoxins into the PO-AH region and the medulla oblongata of the rat. Experientia (1973) 0.88
Does the duration of cardiopulmonary bypass or aortic cross-clamp, in the absence of blood and/or blood product administration, influence the IL-6 response to cardiac surgery? Anesth Analg (1998) 0.87
Monocyte-derived macrophage function in HIV-infected subjects: in vitro modulation by rIFN-gamma and rGM-CSF. Clin Immunol Immunopathol (1992) 0.87
alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation and IkappaBalpha degradation in human glioma cells and in experimental brain inflammation. Exp Neurol (1999) 0.87